Login to Your Account

Other News To Note

Monday, October 10, 2011
Adherex Technologies Inc., of Research Triangle Park, said the FDA's Pediatric Subcommittee of the Oncologic Drugs Advisory Committee will discuss the development of sodium thiosulfate injection, USP, 20 percent (STS) Nov. 1.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription